Revenue: The sum of all revenue fields included for a company's operating activities.
Y-mAbs Therapeutics, Inc. (YMAB) had Revenue of $20.90M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$20.90M |
$-5.20M |
|
$3.00M |
|
$17.90M |
|
$27.45M |
|
$-6.54M |
|
$1.35M |
|
$-5.19M |
|
$-5.19M |
|
$-5.20M |
|
$-5.20M |
|
$-5.20M |
|
$-5.20M |
|
$-6.54M |
|
$-6.47M |
|
45.10M |
|
45.10M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$90.45M |
|
$0.16M |
|
$22.16M |
|
$112.61M |
|
$18.96M |
|
-- |
|
$4.20M |
|
$23.16M |
|
$89.46M |
|
$87.24M |
|
$89.46M |
|
45.25M |
|
| Cash Flow Statement Financials | |
$-6.91M |
|
$-0.13M |
|
$0.11M |
|
$67.23M |
|
$60.31M |
|
$-6.92M |
|
$3.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
85.64% |
|
-31.30% |
|
-31.30% |
|
-- |
|
-24.83% |
|
-24.86% |
|
$-7.04M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.38 |
|
1.18 |
|
76.38 |
|
-5.81% |
|
-5.96% |
|
-4.61% |
|
-5.81% |
|
$1.98 |
|
$-0.16 |
|
$-0.15 |
|